跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 348 条关于
“DILI”
全部
348
临床试验
132
药物
12
机构
2
资讯
202
去年
CN Bio Expands FDA-Recognized DILI Assay with Cross-Species Models to Improve Drug Safety Predictions
去年
Expert Consensus Provides Guidance on Drug-Induced Liver Injury in Oncology Trials
去年
SKYCLARYS PASS Registry to Monitor Long-Term Safety of Omaveloxolone in Friedreich Ataxia
8天前
Genencell COVID-19 Drug ES16001 Approved for Phase 2/3 Without Liver-Injury Endpoint Despite Phase 1 Enzyme Elevations
3年前
F2G's Olorofim Shows 44% Response Rate in Phase 2b Trial for Invasive Fungal Infections
去年
Lilly's Jaypirca Shows Promise in BTK Inhibitor-Pretreated CLL/SLL
3个月前
FDA Accepts AI-Based Digital Liver Model into ISTAND Program to Predict Drug-Induced Liver Injury
上个月
WHO SEARO and University of Colombo Sign Agreement to Scale AI-Enabled Precision Medicine Across South-East Asia
9个月前
Sanofi's Tolebrutinib Fails Phase 3 Trial in Primary Progressive Multiple Sclerosis
7个月前
VivoSim Labs Expands Human-Based Toxicology Services to Asia-Pacific Through Strategic Distribution Partnerships
第 1 页,共 21 页
上一页
下一页